Literature DB >> 3889802

Acute lymphoblastic leukemia in childhood.

D G Poplack.   

Abstract

This article reviews those factors that have been responsible for progress in the past, describes current biologic and therapeutic approaches to ALL, and discusses those unresolved treatment issues that pose the major challenge for the future.

Entities:  

Mesh：

Year:  1985        PMID： 3889802     DOI： 10.1016/s0031-3955(16)34831-3

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN： 0031-3955            Impact factor:   3.278


  8 in total

1.  Immunogenetics and the aetiology of childhood leukaemia.

Authors:  G M Taylor
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

Review 2.  Prospects for cure in leukaemia.

Authors:  J M Goldman
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

3.  Initial blood fetal hemoglobin concentration is elevated and is associated wtih prognosis in children with acute lymphoid or myeloid leukemia.

Authors:  J Rautonen; M A Siimes
Journal:  Blut       Date:  1990-07

4.  Rectal bioavailability of 6-mercaptopurine in children with acute lymphoblastic leukaemia: partial avoidance of "first-pass" metabolism.

Authors:  Y Kato; T Matsushita; H Uchida; S Egi; T Yokoyama; K Mohri
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Decline in head growth and cognitive impairment in survivors of acute lymphoblastic leukaemia.

Authors:  R E Appleton; K Farrell; J Zaide; P Rogers
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

6.  Intraindividual variation in 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute lymphoblastic leukaemia.

Authors:  P Lafolie; S Hayder; O Björk; C Peterson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  6-Mercaptopurine in cerebrospinal fluid during oral maintenance therapy of children with acute lymphoblastic leukemia.

Authors:  S Hayder; P Lafolie; O Björk; L Ahström; C Peterson
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

8.  Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate.

Authors:  F Innocenti; R Danesi; A Di Paolo; B Loru; C Favre; M Nardi; G Bocci; D Nardini; P Macchia; M Del Tacca
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.